Preparation of a novel streptokinase mutant with improved stability
- PMID: 9609235
Preparation of a novel streptokinase mutant with improved stability
Abstract
The novel mutant streptokinase, SK-K59E, can activate human plasminogen as efficiently as the purified commercially available streptokinase. Several peptide bonds including Lys59-Ser60 in native streptokinase were hydrolyzed in reaction with plasmin and peptides of small molecular masses were generated. The plasminogen activator activity of native streptokinase in reaction with human plasmin declined to 25% of the original activity in a 120-min incubation. On the other hand, the NH2-terminal peptide of SK-K59E remained intact in reaction with plasmin and the activator activity of streptokinase decreased to 75% of the original activity in 120 min. The major degraded peptide fragments of native streptokinase in reaction with plasmin had molecular masses of 36 and 30 kDa. However, two major peptide fragments of 42 and 34 kDa were observed in the reaction of SK-K59E with human plasmin. The 42 kDa peptide fragment, which contained NH2-terminal of streptokinase, could activate human plasminogen as efficiently as the native streptokinase. SK-K59E can induce greater degree of caseinolysis and fibrinolysis than the native streptokinase. In conclusion, the results demonstrate that the prevention of cleavage at Lys59 of streptokinase prolongs the half-life of streptokinase in complex with plasmin and that the NH2-terminal of streptokinase (Ile1-Lys59) plays an important role in maintaining its stability.
Similar articles
-
Functional analysis of the amino- and carboxyl-termini of streptokinase.Thromb Haemost. 1998 May;79(5):985-91. Thromb Haemost. 1998. PMID: 9609234
-
Function of streptokinase fragments in plasminogen activation.Biochem J. 1994 Nov 15;304 ( Pt 1)(Pt 1):235-41. doi: 10.1042/bj3040235. Biochem J. 1994. PMID: 7998939 Free PMC article.
-
Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis.Protein Sci. 1999 Dec;8(12):2791-805. doi: 10.1110/ps.8.12.2791. Protein Sci. 1999. PMID: 10631997 Free PMC article.
-
Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues.Trends Biochem Sci. 2000 Feb;25(2):53-9. doi: 10.1016/s0968-0004(99)01521-2. Trends Biochem Sci. 2000. PMID: 10664583 Review.
-
The activation mechanism of human plasminogen.Thromb Diath Haemorrh. 1975 Nov 15;34(2):386-95. Thromb Diath Haemorrh. 1975. PMID: 128150 Review. No abstract available.
Cited by
-
Structural Biology and Protein Engineering of Thrombolytics.Comput Struct Biotechnol J. 2019 Jul 2;17:917-938. doi: 10.1016/j.csbj.2019.06.023. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31360331 Free PMC article. Review.
-
The evolution of recombinant thrombolytics: Current status and future directions.Bioengineered. 2017 Jul 4;8(4):331-358. doi: 10.1080/21655979.2016.1229718. Epub 2016 Oct 3. Bioengineered. 2017. PMID: 27696935 Free PMC article.
-
Translational initiatives in thrombolytic therapy.Front Med. 2017 Mar;11(1):1-19. doi: 10.1007/s11684-017-0497-8. Epub 2017 Mar 2. Front Med. 2017. PMID: 28116631 Review.